TYRO3 protects podocyte via JNK/c-jun-P53 pathway.

Area of Science:

• Nephrology
• Molecular Biology
• Cell Biology

Background:

• Podocyte injury is central to diabetic kidney disease (DKD) pathogenesis.
• The protective role of tyrosine-protein kinase receptor TYRO3 (TYRO3) in glomerular disease is known, but its downstream signaling remains unelucidated.
• Understanding TYRO3's molecular mechanisms is crucial for DKD therapeutic strategies.

Purpose of the Study:

• To investigate the downstream signaling pathways of TYRO3 in podocyte homeostasis.
• To elucidate the role of TYRO3 in the context of diabetic kidney disease (DKD).
• To identify novel molecular insights into TYRO3-mediated podocyte protection.

Main Methods:

• Genetic ablation of tyro3 in zebrafish to model nephrotic syndrome.
• In vitro studies involving high glucose and TGF-β treatment to assess TYRO3 expression.
• siRNA-mediated knockdown of TYRO3 in podocytes to analyze apoptosis and cytoskeleton rearrangement.
• Western blot analysis to examine the activation of JNK/c-jun-P53 signaling pathway.

Main Results:

• Genetic ablation of tyro3 in zebrafish induced a nephrotic syndrome phenotype.
• High glucose and TGF-β suppressed TYRO3 expression, mimicking findings in progressive DKD.
• TYRO3 knockdown led to podocyte apoptosis and cytoskeleton rearrangement.
• TYRO3 activation of JNK/c-jun-P53 signaling conferred antiapoptotic effects in podocytes.

Conclusions:

• TYRO3 plays a critical role in maintaining podocyte homeostasis.
• TYRO3 exerts antiapoptotic effects in podocytes through the JNK/c-jun-P53 pathway.
• This study reveals a novel signaling module for TYRO3, offering new molecular insights into its protective effects in DKD.